Vectalys Private

Vectalys is a private biotech company founded in 2005 by Pascale Bouillé. With a team of 25 employees, Vectalys specializes in gene delivery using lentiviral vectors. Their goal is to help scientists worldwide understand cellular and molecular mechanisms to discover new drugs and therapies. Vectalys has developed a proprietary technology that provides high-quality lentiviral vectors for transducing hard-to-transfect cells, ensuring 100% transduction efficiency and non-toxic transduction. They also offer custom lentiviral vectors and ready-to-use lentiviral vectors with fluorescent, bioluminescent, or gene editing proteins, which are distributed globally. Vectalys is dedicated to providing solutions that save time and support ambitious research projects.

Investors

Industry: Stem Cells (Regenerative Medicine)
Investors Number: 5
Technology: Regenerative Medicine
Last Funding Type: Venture - Series Unknown
Headquarters: Toulouse, Midi-Pyrenees, France
Founded Date: 2005-01-01
Investor Type: For Profit
Funding Status: M&A
Total Funding: €4.8M
Estimated Revenue: $1M to $10M
Employee Number: Nov-50
Register and Claim Ownership